Asian Markets Stumble Wednesday

Asian markets sustained deep losses Wednesday after setbacks in the search for a COVID-19 vaccine or therapeutic drug caused uncertainty among investors.
Japan’s benchmark Nikkei index was the region’s lone brightspot, finishing 0.1% higher. The S&P/ASX index in Australia was down 0.2%. Hong Kong’s Hang Seng index lost seven points, but was unchanged percentage-wise. Shanghai’s Composite index closed 0.5% lower. South Korea’s KOSPI index fell 0.9%, and the TSEC index in Taiwan ended the trading session 0.2% lower.
The Sensex in India is down 0.6% in late afternoon trading.
U.S. drugmaker Eli Lilly said Tuesday that clinical trials of its experimental coronavirus antibody treatment were being paused for safety reasons. Another U.S. pharmaceutical giant, Johnson & Johnson, revealed the day before that it was putting a hold on a late-stage trial of a potential vaccine after a participant became ill.
In commodities trading, gold was selling at $1,899.80, up 0.2%. U.S. crude oil is selling at $39.98 per barrel, down 0.5%, and Brent crude oil is trading at $42.25 per barrel, down 0.4%.
All three major U.S. indices are trending positively in futures trading.

Source: Voice of America


Argentina Relaxes COVID-19 Restrictions

Authorities in Buenos Aires have loosened coronavirus restrictions, allowing people inside businesses, including restaurants, bars and gyms for the first time in seven months. Under the new guidelines, businesses are allowed up to 25 percent of their c…

Asian Markets Undergoing a Second Consecutive Down Day

The shockwaves from Monday’s major losses on Wall Street are reverberating throughout Asian financial markets Tuesday. The Nikkei index in Tokyo lost eight points, but was unchanged percentage-wise. Sydney’s S&P/ASX index dropped 1.7%. The KOSPI index…